Sika Interplant Systems Limited Submits SEBI Compliance Certificate for March 2026 Period

1 min read     Updated on 14 Apr 2026, 11:46 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Sika Interplant Systems Limited filed a mandatory SEBI compliance certificate for the period 01.03.2026 to 31.03.2026, confirming no dematerialisation or rematerialisation requests were received. Company Secretary Suraj Kumar Sahu submitted the certificate to BSE on 14th April 2026, with confirmation provided by registrar Integrated Registry Management Services Private Limited.

powered bylight_fuzz_icon
37692961

*this image is generated using AI for illustrative purposes only.

Sika Interplant Systems Limited has submitted its mandatory compliance certificate to BSE Limited under SEBI regulations for the March 2026 period. The filing demonstrates the company's adherence to regulatory requirements governing share transfer and dematerialisation processes.

Regulatory Compliance Certificate

The company filed a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 covering the period from 01.03.2026 to 31.03.2026. Company Secretary and Compliance Officer Suraj Kumar Sahu submitted the documentation to BSE Limited on 14th April 2026.

Parameter: Details
Filing Date: 14th April 2026
Period Covered: 01.03.2026 to 31.03.2026
Regulation: SEBI Regulation 74(5)
Filed By: Suraj Kumar Sahu, Company Secretary

Share Transfer Agent Confirmation

Integrated Registry Management Services Private Limited, serving as the company's registrar and share transfer agent, issued the compliance certificate on 6th April 2026. General Manager S Giridhar confirmed that the agency received no requests for dematerialisation or rematerialisation of shares during the specified period.

The certificate specifically states: "we hereby confirm that we have not received any request for dematerialisation or rematerialisation of shares for the period 01.03.2026 to 31.03.2026."

Corporate Information

Sika Interplant Systems Limited maintains its registered office at No 03 Gangadhar Chetty Road, Dr. Sharma Building, Bangalore – 560 042. The company's shares are listed on BSE with scrip code 523606 and ISIN INE438E01032.

Integrated Registry Management Services Private Limited operates from Bangalore with its registered office in Chennai. The agency holds SEBI registration number INR000000544 and provides both share-related and fixed deposit services to corporate clients.

Historical Stock Returns for Sika Interplant Systems

1 Day5 Days1 Month6 Months1 Year5 Years
+0.53%+9.74%-5.80%-25.15%+47.84%+1,573.51%

What factors might be contributing to the absence of dematerialisation requests, and could this indicate low trading activity or investor interest in Sika Interplant Systems?

How might upcoming regulatory changes in SEBI's depositories framework affect Sika Interplant Systems' compliance processes in future quarters?

Will Sika Interplant Systems consider switching registrar and transfer agents if share trading volumes increase significantly?

Sika Interplant Systems
View Company Insights
View All News
like19
dislike

Sika Interplant Systems Q3FY26 Results: Net Profit Surges 43% to ₹949.89 Lakhs on Strong Revenue Growth

2 min read     Updated on 10 Mar 2026, 11:27 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Sika Interplant Systems Limited reported exceptional Q3FY26 results with net profit surging 43.17% to ₹949.89 lakhs and revenue growing 32.46% to ₹5,030.96 lakhs. Nine-month performance was even stronger, with net profit rising 64.84% to ₹2,885.33 lakhs and revenue increasing 67.15% to ₹16,989.74 lakhs. The company maintained strong operational efficiency while scaling business operations and holds a robust balance sheet with total assets of ₹18,368.55 lakhs.

powered bylight_fuzz_icon
34667862

*this image is generated using AI for illustrative purposes only.

Sika Interplant Systems Limited delivered impressive financial results for the third quarter ended December 31, 2025, demonstrating strong operational performance across key metrics. The Bangalore-based engineering products and systems company reported significant growth in both revenue and profitability.

Strong Q3FY26 Financial Performance

The company's standalone financial results showed robust growth across all major parameters:

Metric Q3FY26 Q3FY25 Growth (%)
Revenue from Operations ₹5,030.96 lakhs ₹3,798.25 lakhs +32.46%
Net Profit ₹949.89 lakhs ₹663.40 lakhs +43.17%
Profit Before Tax ₹1,269.34 lakhs ₹886.52 lakhs +43.19%
Basic EPS ₹4.48 ₹3.13 +43.13%

Total income including other income reached ₹5,173.74 lakhs in Q3FY26, representing a substantial increase from ₹3,928.53 lakhs in the corresponding quarter of the previous year.

Nine-Month Performance Highlights

The company's nine-month performance for the period ended December 31, 2025, showed even more impressive growth trajectories:

Parameter 9M FY26 9M FY25 Growth (%)
Revenue from Operations ₹16,989.74 lakhs ₹10,164.36 lakhs +67.15%
Net Profit ₹2,885.33 lakhs ₹1,750.43 lakhs +64.84%
Profit Before Tax ₹3,829.01 lakhs ₹2,339.15 lakhs +63.68%
Basic EPS ₹13.52 ₹8.26 +63.68%

The nine-month total income reached ₹17,450.62 lakhs compared to ₹10,539.13 lakhs in the previous year, marking substantial business expansion.

Operational Efficiency and Cost Management

The company maintained effective cost control while scaling operations. Total expenses for Q3FY26 were ₹3,904.40 lakhs compared to ₹3,042.01 lakhs in Q3FY25. Key expense components included:

  • Cost of materials consumed: ₹3,253.11 lakhs
  • Employee benefit expenses: ₹199.98 lakhs
  • Other expenditure: ₹247.97 lakhs
  • Finance costs: ₹8.89 lakhs
  • Depreciation: ₹23.97 lakhs

Balance Sheet Strength

As of December 31, 2025, the company maintained a strong financial position with total assets of ₹18,368.55 lakhs. The balance sheet highlights include:

Component Amount (₹ lakhs)
Property, Plant and Equipment 4,303.08
Investments 6,771.94
Trade Receivables 2,591.45
Cash and Cash Equivalents 993.41
Bank Balances 2,474.68

The company's equity base comprises ₹424.02 lakhs in paid-up equity share capital with a face value of ₹2 per share and ₹14,373.95 lakhs in other equity.

Consolidated Results and Subsidiaries

The consolidated financial results showed similar strong performance, with net profit of ₹948.98 lakhs for Q3FY26 compared to ₹714.25 lakhs in Q3FY25. The consolidated results include four subsidiaries: Aerotek Sika Aviosystem Private Limited, Emsac Engineering Pvt Ltd, Sikka N Sikka Engineers Private Limited, and Sika Tourism Private Limited.

Regulatory Compliance and Board Approval

The Board of Directors approved the unaudited financial results at their meeting held on February 11, 2026, which commenced at 3:00 p.m. and concluded at 4:15 p.m. The company also addressed regulatory discrepancies pointed out by BSE regarding the Limited Review Report and submitted corrected documents on March 10, 2026. The financial results were reviewed by the Audit Committee before Board approval and have been prepared in accordance with Indian Accounting Standards (Ind AS) Rules 2015.

Historical Stock Returns for Sika Interplant Systems

1 Day5 Days1 Month6 Months1 Year5 Years
+0.53%+9.74%-5.80%-25.15%+47.84%+1,573.51%
Sika Interplant Systems
View Company Insights
View All News
like16
dislike

More News on Sika Interplant Systems

1 Year Returns:+47.84%